Follicular lymphoma triggers phenotypic and functional remodeling of the human lymphoid stromal cell landscape.


Journal

Immunity
ISSN: 1097-4180
Titre abrégé: Immunity
Pays: United States
ID NLM: 9432918

Informations de publication

Date de publication:
10 08 2021
Historique:
received: 25 09 2020
revised: 18 03 2021
accepted: 27 05 2021
pubmed: 25 6 2021
medline: 24 9 2021
entrez: 24 6 2021
Statut: ppublish

Résumé

Lymphoid stromal cells (LSCs) are essential organizers of immune responses. We analyzed tonsillar tissue by combining flow cytometry, in situ imaging, RNA sequencing, and functional assays, defining three distinct human LSC subsets. The integrin CD49a designated perivascular stromal cells exhibiting features of local committed LSC precursors and segregated cytokine and chemokine-producing fibroblastic reticular cells (FRCs) supporting B and T cell survival. The follicular dendritic cell transcriptional profile reflected active responses to B cell and non-B cell stimuli. We therefore examined the effect of B cell stimuli on LSCs in follicular lymphoma (FL). FL B cells interacted primarily with CD49a

Identifiants

pubmed: 34166622
pii: S1074-7613(21)00225-9
doi: 10.1016/j.immuni.2021.05.019
pii:
doi:

Substances chimiques

CCL19 protein, human 0
CCL21 protein, human 0
Chemokine CCL19 0
Chemokine CCL21 0
Integrin alpha1 0
TGFB1 protein, human 0
TNF protein, human 0
Transforming Growth Factor beta1 0
Tumor Necrosis Factor-alpha 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1788-1806.e7

Commentaires et corrections

Type : CommentIn
Type : ErratumIn

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Auteurs

Frédéric Mourcin (F)

UMR 1236, Université Rennes, INSERM, Etablissement Français du Sang Bretagne, 35043, Rennes, France.

Léa Verdière (L)

UMR 1236, Université Rennes, INSERM, Etablissement Français du Sang Bretagne, 35043, Rennes, France.

David Roulois (D)

UMR 1236, Université Rennes, INSERM, Etablissement Français du Sang Bretagne, 35043, Rennes, France.

Rada Amin (R)

UMR 1236, Université Rennes, INSERM, Etablissement Français du Sang Bretagne, 35043, Rennes, France.

Claire Lamaison (C)

UMR 1236, Université Rennes, INSERM, Etablissement Français du Sang Bretagne, 35043, Rennes, France.

Vonick Sibut (V)

UMR 1236, Université Rennes, INSERM, Etablissement Français du Sang Bretagne, 35043, Rennes, France.

Brice Thamphya (B)

UMR 1236, Université Rennes, INSERM, Etablissement Français du Sang Bretagne, 35043, Rennes, France.

Céline Pangault (C)

UMR 1236, Université Rennes, INSERM, Etablissement Français du Sang Bretagne, 35043, Rennes, France; Pôle Biologie, CHU Rennes, 35033 Rennes, France.

Céline Monvoisin (C)

UMR 1236, Université Rennes, INSERM, Etablissement Français du Sang Bretagne, 35043, Rennes, France.

Sarah Huet (S)

Université Claude Bernard Lyon I, Equipe Lymphoma Immuno Biology, Equipe Labellisée par la Ligue Nationale contre le Cancer, 69921 Oullins, France; Hospices Civils de Lyon, Service d'hématologie biologique, 69395 Pierre-Bénite, France.

Marine Seffals (M)

UMS Biosit, Core Facility H2P2, Université Rennes, INSERM, CNRS, Rennes, 35043, France.

Sylvain Baulande (S)

Institut Curie Genomics of Excellence (ICGex) Platform, Institut Curie Research Center, PSL Research University, 75005, Paris, France.

Fatima Mechta-Grigoriou (F)

Institut Curie, Stress and Cancer Laboratory, Equipe Labellisée par la Ligue Nationale contre le Cancer, PSL Research University, 26, rue d'Ulm, 75248 Paris, France.

Patricia Legoix (P)

Institut Curie Genomics of Excellence (ICGex) Platform, Institut Curie Research Center, PSL Research University, 75005, Paris, France.

Delphine Rossille (D)

UMR 1236, Université Rennes, INSERM, Etablissement Français du Sang Bretagne, 35043, Rennes, France; Pôle Biologie, CHU Rennes, 35033 Rennes, France.

Marion Guirriec (M)

UMR 1236, Université Rennes, INSERM, Etablissement Français du Sang Bretagne, 35043, Rennes, France.

Simon Léonard (S)

UMR 1236, Université Rennes, INSERM, Etablissement Français du Sang Bretagne, 35043, Rennes, France.

Guillaume Cartron (G)

Department of Hematology, CHU Montpellier, 34000, Montpellier, France.

Gilles Salles (G)

Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Thierry Fest (T)

UMR 1236, Université Rennes, INSERM, Etablissement Français du Sang Bretagne, 35043, Rennes, France; Pôle Biologie, CHU Rennes, 35033 Rennes, France.

Karin Tarte (K)

UMR 1236, Université Rennes, INSERM, Etablissement Français du Sang Bretagne, 35043, Rennes, France; Pôle Biologie, CHU Rennes, 35033 Rennes, France. Electronic address: karin.tarte@univ-rennes1.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH